<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="21147">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02831595</url>
  </required_header>
  <id_info>
    <org_study_id>VCG-30-2015</org_study_id>
    <nct_id>NCT02831595</nct_id>
  </id_info>
  <brief_title>Effectiveness of Titanium Niobium Nitride Coating in Total Knee Arthroplasty</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Permedica Manufacturing</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Permedica Manufacturing</source>
  <brief_summary>
    <textblock>
      Modern knee implants combine several types of metal and therefore potentially expose
      patients to different metal ions.

      Titanium niobium nitride coating (TiNbN) acts like a physical barrier against the corrosion
      process and the metallic ions release towards the surrounding biologic environment, thus,
      making TiNbN-coated prostheses possible to be safety implanted in metal sensitized patients.

      The aim of the study is to verify that the postoperative plasma metal concentrations at 1
      year are not different than preoperative values.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>June 2016</start_date>
  <primary_completion_date type="Anticipated">October 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Change from baseline plasma metal ion concentrations (Co, Cr, Ni) at 12 months</measure>
    <time_frame>Preoperative and at 12 months follow-up</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of patients with metal sensitivity at 1 year tested by patch-testing</measure>
    <time_frame>1 year follow-up</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">80</enrollment>
  <condition>Knee Arthritis</condition>
  <arm_group>
    <arm_group_label>Patients undergoing unilateral TKA</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>GKS Prime Flex Bioloy by Permedica, a TiNbN coated fixed-bearing cruciate-retaining total knee prosthesis</intervention_name>
    <arm_group_label>Patients undergoing unilateral TKA</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with a diagnosis of knee osteoarthritis scheduled for unilateral TKA
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients candidate for unilateral primary total knee arthroplasty

        Exclusion Criteria:

          -  Existing orthopaedic metal implants

          -  A history of hypersensitivity to metals

          -  Preoperative patch-test positivity to Co, Cr, Ni and Ti

          -  Malignancies

          -  Renal insufficiency

          -  Severe illnesses that would impair participation in this study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nicola Ursino, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>IRCCS Istituto Ortopedico Galeazzi Milano, Italy</affiliation>
  </overall_official>
  <verification_date>June 2016</verification_date>
  <lastchanged_date>July 8, 2016</lastchanged_date>
  <firstreceived_date>June 29, 2016</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
